At the 2024 CCHIO Lung Tumor Integrated Rehabilitation Session, Dr. Dingzhi Huang from Tianjin Medical University Cancer Institute and Hospital delivered a presentation titled “Advances in SCLC Treatment.” Below is a comprehensive summary of the key highlights.

Immunotherapy, represented by immune checkpoint inhibitors (ICIs), has rapidly advanced in the treatment of lung cancer in recent years. However, challenges remain, such as limited efficacy with monotherapy and increased side effects with combination therapies. Multi-targeted combination therapies represent a potential avenue for advancing immunotherapy. Among them, bispecific antibodies (BsAbs), which simultaneously target two different antigens or epitopes, have emerged as a focus of attention for their ability to enhance the immune system's recognition and destruction of tumor cells.

From November 22 to 24, 2024, the CSCO Gastric Cancer Committee Annual Meeting convened in Beijing, gathering leading experts to discuss the latest advancements, challenges, and opportunities in gastric cancer management. Dr. Ting Deng from Tianjin Medical University Cancer Institute and Hospital delivered a keynote presentation titled "ADC Combination Strategies for Gastric Cancer: Directions and Advances."

The 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) concluded on November 17, emphasizing a multidisciplinary approach to oncology. The event featured specialized sessions on integrated rehabilitation, public education, and cancer prevention, showcasing novel perspectives and techniques for comprehensive cancer care. During the conference, Oncology Frontier had the honor of interviewing Dr. Xiuyi Zhi, Chief Expert of Thoracic Surgery at Xuanwu Hospital, Capital Medical University, and Director of the Public Education Department of the Chinese Anti-Cancer Association (CACA). Professor Zhi shared the progress in cancer education initiatives and the development of cancer prevention awareness in China.

On November 15, 2024, the 4th Asian Oncology Society opened grandly in Xi'an, China. Held alongside the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO), this event, co-hosted by the Chinese Anti-Cancer Association and the Asian Oncology Society (AOS), was themed "Integration and Modernity." It brought together oncology experts from across Asia to explore new cancer control strategies and clinical practice advancements. During the conference, Oncology Frontier had the privilege of interviewing Prof. Han Kwang Yang, Secretary-General of AOS and a renowned expert from Seoul National University Hospital, to discuss AOS’s mission and vision for the future.

From November 14–17, the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the Asian Oncology Society (AOS 2024) convened in Xi'an. Jointly organized by the Chinese Anti-Cancer Association (CACA), the Union for International Cancer Control (UICC), and the National Comprehensive Cancer Network (NCCN®), the event featured a specialized session on "International Collaboration: CACA-UICC & CACA-NCCN."

The 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) recently convened in Xi'an, bringing together global experts and scholars to discuss the latest advancements in cancer treatment and foster international cooperation. Among the distinguished participants was Prof. Naoufal Louati, President of the Moroccan Institute of Traditional Chinese Medicine, who delivered a keynote presentation titled "Global Progress on Holistic Cancer Care." Following his address, Oncology Frontier interviewed Prof. Louati to discuss his experience at the conference, his insights into the role of Traditional Chinese Medicine (TCM) in cancer treatment, and the promising prospects for China-Morocco collaboration in cancer research and prevention.

Dear colleagues in the medical field, the 14th Shanghai Genitourinary Oncology Academic Conference & Annual Meeting of Chinese Anti-Cancer Association-Genital Oncology Committee (CACA-GO) will be held grandly from December 6th to 8th ! This is a "highlight moment" in the field of urology. It focuses on the cutting-edge progress and innovative achievements. Many top-notch experts and scholars from both home and abroad will gather together to conduct in-depth discussions, covering multiple aspects such as surgical innovation, basic research, and translational medicine, presenting a veritable "feast" of academic knowledge.